ALMIRALL, S.A. «...1617» Page 16 out of 17 27/07/2020 07:23 ALMIRALL, S.A. On business and financial situation First semester results presentation 2020 Register number: 3619 27/07/2020 07:21 ALMIRALL, S.A. Half-yearly financial reports and audit reports/limited audit review La sociedad remite información financiera del primer semestre de 2020 Register number: 3618 27/07/2020 07:18 ALMIRALL, S.A. On business and financial situation Almirall announces that a webcast with analysts and institutional investors will be held today at 10.00 am CET related to the H1 2020 Financial Results. Register number: 3617 24/07/2020 17:24 ALMIRALL, S.A. Other relevant information Comisión de Dermatología de la Compañía Register number: 3610 24/07/2020 17:19 ALMIRALL, S.A. Announcement of general shareholders’ meeting Acuerdos adoptados por la Junta General de Accionistas 2020 Register number: 3609 20/07/2020 17:37 ALMIRALL, S.A. Other relevant information Almirall refinancia la línea de crédito revolving Register number: 3488 25/06/2020 19:15 ALMIRALL, S.A. Other relevant information Almirall S.A. divests Ansiolin® to Neuraxpharm in Italy Register number: 2996 10/06/2020 17:39 ALMIRALL, S.A. Announcement of general shareholders’ meeting Convocatoria Junta General Ordinaria para su celebración por medios exclusivamente telemáticos Register number: 2695 11/05/2020 07:36 ALMIRALL, S.A. Other relevant information Conference Call with analysts and Institutional investors Register number: 2150 11/05/2020 07:26 ALMIRALL, S.A. Interim management report La sociedad remite declaración intermedia de gestión del primer trimestre de 2020 Register number: 2149 Page 16 out of 17 «...1617»